Study of lower radiation and chemo for head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This study tests whether giving lower doses of radiation and chemotherapy is safe and effective for people with certain head and neck cancers. It aims to reduce side effects while keeping the treatment successful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of squamous cell carcinoma of the head and neck.
- Your cancer must not be in the nasopharynx, nasal cavity, paranasal sinuses, oral cavity, salivary glands, or thyroid.
- If your cancer is in the oropharynx or of unknown origin, it must test negative for p16.
- Your cancer stage must be T0-3, N1-2C, M0 (no distant spread) based on the AJCC 7th edition.
- You must be at least 18 years old.
- You must not have had prior radiation or chemotherapy for this cancer.
- You must have adequate blood counts, kidney, and liver function.
- If you are able to become pregnant, you must have a negative pregnancy test before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether planning radiation based on an imaging scan (F-MISO PET) can better target oxygen-poor (low-oxygen) tumor areas in head and neck cancer. It may help make radiation more precise while still using standard curative treatment.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This Phase 2 study tests whether giving low-dose radiation before surgery—along with chemotherapy and an immunotherapy drug—can work better and be safe for treating locally advanced head and neck squamous cell cancer. It may help shrink tumors before surgery and reduce the chance of the cancer coming back.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.